Showing results (501-510 of 520) with videos related to
Sort By:
Pageof 52
BMC Nephrology|May 26, 2025
Fabry disease in the haemodialysis population: outcome of a UK screening study (SoFAH)K P Ng, M Sandhu, D Banerjee, et al.Clinical Pharmacokinetics|March 27, 2025
Pharmacokinetics and Safety of Navitoclax in Hepatic ImpairmentMaulik Patel, Jalaja Potluri, Thomas Marbury, et al.Nano Letters|January 5, 2023
Spin Dynamics of a Solid-State Qubit in Proximity to a SuperconductorRichard Monge, Tom Delord, Nicholas V Proscia, et al.Nature Communications|November 28, 2024
Million-Q free space meta-optical resonator at near-visible wavelengthsJie Fang, Rui Chen, David Sharp, et al.Pediatric Blood & Cancer|September 7, 2022
Pulmonary hypertension screening in children with sickle cell diseaseKok Hoe Chan, Syeda Hiba Rizvi, Wilfredo De Jesus-Rojas, et al.Iscience|July 20, 2026
HDAC-driven autophagy repression aids macrophage immune evasion by K. pneumoniae strains displaying classical, MDR, and hypervirulent phenotypesKuniyil Abhinand, Shima Merin Sony, Avandika B Anil, et al.ACS Nano|December 20, 2022
Sensing the Local Magnetic Environment through Optically Active Defects in a Layered Magnetic SemiconductorJulian Klein, Zhigang Song, Benjamin Pingault, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 27, 2015
Medical androgen deprivation therapy and increased non-cancer mortality in non-metastatic prostate cancer patients aged ≥66 yearsF Abdollah, J D Sammon, G Reznor, et al.Journal of Vascular and Interventional Radiology : JVIR|February 11, 2024
Radioembolization plus Immune Checkpoint Inhibitor Therapy Compared with Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular CarcinomaKirema Garcia-Reyes, Ricki A Gottlieb, Kartikeya M Menon, et al.Nature Communications|November 18, 2025
Free space few-photon nonlinearity in critically coupled polaritonic metasurfacesJie Fang, Abhinav Kala, Rose Johnson, et al.Pageof 52